Clinical Trial

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Study acronym: FACILITATE
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a pilot imaging study in participants treated with stereotactic radiosurgery (SRS) to treat brain metastasis. The purpose of this study is to see whether 18F-Fluciclovine positron emission tomography (PET) can be used as a biomarker to measure response or progression of brain metastasis after SRS.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-09-15; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Recruiting 2024-04-16
Trial Details
NCT Number NCT06048094
Lead Sponsor Baptist Health South Florida
Collaborators: Blue Earth Diagnostics
Conditions Brain Metastases, Brain Metastases, Adult, Brain Cancer
Enrollment 46 participants
Start Date 2024-04-11
Primary Completion 2032-06 (estimated)
Study Completion 2033-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-20